SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 8:30 a.m., Pacific Standard Time (11:30 a.m., Eastern Standard Time).
The presentation will be available through the conference website at http://metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=VOLC and via the company's website at http://www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices
designed to facilitate endovascular procedures, enhance the diagnosis of
vascular and structural heart disease and guide optimal therapies. The
company's intravascular ultrasound (IVUS) product line includes ultrasound
consoles that can be integrated directly into virtually any modern cath lab.
Volcano IVUS offers unique features, including both single-use phased array
and rotational IVUS imaging catheters, and advanced functionality options,
such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also
provides functional measurement (FM) consoles and single-use pressure and flow
guide wires and is developing a line of ultra-high resolution Optical
Coherence Tomography (OCT) systems and catheters. Currently, more than 3,700
Volcano IVUS and FM systems are installed worldwid
|SOURCE Volcano Corporation|
Copyright©2009 PR Newswire.
All rights reserved